| Issue |
Section |
Title |
File |
| Vol 94, No 1 (2022) |
Original articles |
ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis |
(Rus)
|
| Vol 93, No 8 (2021) |
Editorial |
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management |
(Rus)
|
| Vol 93, No 8 (2021) |
Original articles |
Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic |
(Rus)
|
| Vol 94, No 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
(Rus)
|
| Vol 94, No 8 (2022) |
Original articles |
Esophagoprotective therapy in patients with erosive esophagitis |
(Rus)
|
| Vol 94, No 8 (2022) |
Clinical notes |
Masks hiding mitochondrial neurogastrointestinal encephalomyopathy. Case report |
(Rus)
|
| Vol 94, No 12 (2022) |
Reviews |
Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review |
(Rus)
|
| Vol 95, No 2 (2023) |
Original articles |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
(Rus)
|
| Vol 95, No 8 (2023) |
Clinical notes |
Diagnostics and treatment of intraductal papillary mucinous pancreas neoplasm |
(Rus)
|
| Vol 96, No 12 (2024): VARIO (РАЗНОЕ) |
Reviews |
Rebamipide: thirty years of experience. A review |
(Rus)
|
